Review
Accepted on 30 Dec 2024
Mechanistic Insights into the Role of Traditional Chinese Medicine in Treating Gastric Cancer
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1443686
Type at least 3 characters
646 articles
Articles
Original Research
Accepted on 27 Dec 2024
Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1518567
Clinical Trial
Accepted on 27 Dec 2024
Changes in Gut Microbiota after Gastric Cancer Surgery: A prospective longitudinal study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1533816
Original Research
Accepted on 26 Dec 2024
Triptolide suppresses IL-1β-induced expression of interleukin-8 by inhibiting ROS-Mediated ERK, AP-1, and NF-κB molecules in human gastric cancer AGS cells
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1498213
Case Report
Accepted on 24 Dec 2024
Case report: detection and treatment of a rare submucosal gland duct adenoma of the esophagus
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1482068
Original Research
Published on 24 Dec 2024
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on cholesterol metabolism in gastric cancer
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1518010
- 288 views
Case Report
Accepted on 23 Dec 2024
Innovative Approach to Esophageal Cancer with Right Aortic Arch: Neoadjuvant Immunotherapy and 3D Reconstruction
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1496265
Original Research
Published on 23 Dec 2024
U-shaped relationship between serum uric acid and gastric cancer risk: a large prospective cohort study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1482814
- 176 views
Original Research
Accepted on 20 Dec 2024
Identification of Biomarkers for Tumor Regression Grade in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Chemoradiotherapy
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1426592
Original Research
Accepted on 19 Dec 2024
Efficacy and prognosis biomarker of locally advanced ESCC patients treated with neoadjuvant chemotherapy and anti-PD-1 immunotherapy
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1498675
Original Research
Accepted on 19 Dec 2024
Efficacy Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy in Patients with Locally Advanced Gastric Cancer: A Retrospective Study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1503045
Original Research
Published on 18 Dec 2024
Identifying subtle differences : a radiomics model assessment for gastric schwannomas and gastrointestinal stromal tumors across risk grades
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1467665
- 149 views
Original Research
Published on 18 Dec 2024
Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1499384
- 233 views
Original Research
Accepted on 16 Dec 2024
Higher 3-Year Recurrence-Free Survival Rate in Patients with Complete Pathological Remission Following Neoadjuvant Chemotherapy Plus Immunotherapy for Esophageal Cancer: A Two-Center, Propensity Score Matching Study
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1463936
Methods
Accepted on 16 Dec 2024
Machine Learning Based Models for Predicting Presentation Delay Risk Among Gastric Cancer Patients
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1503047
- 110 views
Original Research
Accepted on 16 Dec 2024
Dual-positive gastric cancer: An extremely malignant subtype of gastric cancer with high serum alpha-fetoprotein and carcinoembryonic antigen concentrations
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1514069
- 104 views